What It Is

Good Manufacturing Practice (GMP), including FDA 21 CFR Parts 210/211 cGMP, is a regulatory framework establishing minimum standards for manufacturing controls. It ensures products like pharmaceuticals and biologics are consistently produced to quality criteria through preventive, risk-based approaches like Quality Risk Management (QRM), focusing on people, premises, processes, procedures, and products.

Key Components

• Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
• Quality Management System (PQS per ICH Q10), documentation, validation, independent quality oversight
• Built on ICH Q9 QRM, continual improvement via CAPA, change control
• Enforced via inspections; no central certification but compliance demonstrated through audits

Why Organizations Use It

GMP protects patients, ensures market access, reduces recalls/liability. Legally mandatory in regulated markets (FDA, EU, WHO); mitigates contamination/mix-up risks; builds stakeholder trust and supply reliability.

Implementation Overview

Phased approach: gap analysis, Validation Master Plan, training, qualification (IQ/OQ/PQ), audits. Applies to pharma/biologics manufacturers globally; requires ongoing inspections, no formal certification but regulatory approval.

What It Is

The UK General Data Protection Regulation (UK GDPR) is the UK's post-Brexit adaptation of the EU GDPR, a binding legal regulation alongside the Data Protection Act 2018, enforced by the Information Commissioner’s Office (ICO). It applies a risk-based, accountability-focused approach to safeguard personal data of UK individuals, including extraterritorial scope for non-UK entities targeting the UK.

Key Components

• **Seven core principleslawfulness/fairness/transparency, purpose limitation, data minimisation, accuracy, storage limitation, integrity/confidentiality, accountability.
• Data subject rights (access, rectification, erasure, portability, objection).
• Controller/processor obligations, lawful bases, security/breaches, DPIAs. No formal certification; compliance via demonstrable records (e.g., RoPA) and ICO audits.

Why Organizations Use It

• Mandatory for legal compliance, avoiding fines up to £17.5m or 4% global turnover.
• Mitigates risks from breaches/enforcement; builds trust/reputation.
• Drives efficiency via data governance; competitive edge in privacy-conscious markets.

Implementation Overview

Phased: data mapping/RoPA, policies/contracts, training, DPIAs, monitoring. Applies to most organizations handling UK personal data; scalable by size/industry.